Search for Clinical Trial Results

Sponsored By

Leukemia-Lymphoma, Adult T-Cell - 25 Studies Found

Status Study
Active, not recruiting Study Name: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Condition: Adult T-cell Leukemia-Lymphoma
Date: 2012-06-19
Interventions:
  • Biological: KW-0761 1.0 mg/kg

Active, not recruiting Study Name: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Condition: Adult T-Cell Leukemia (ATL)
Date: 2009-06-17
Interventions:
  • Drug: LMB-2 Begin with 30 mcg/
Terminated Study Name: Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma
Condition:
  • Cutaneous T-Cell Lymphoma
  • Leukemia-Lymphoma, Adult T-Cell

    • Date: 2008-06-13
    Interventions: Drug: Panobinostat (LBH589) 20mg/day p.o. on three times-a- week
Recruiting Study Name: Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)
Condition: Adult T-Cell Lymphoma (ATL)
Date: 2016-11-01
Interventions: Drug: HBI-8000 Oral, twice weekly
Completed Study Name: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma
Condition: Adult T-cell Leukemia-lymphoma
Date: 2009-06-09
Interventions: Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at
Completed Study Name: Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Condition: Adult T Cell Leukemia/Lymphoma
Date: 2011-01-10
Interventions: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc
Active, not recruiting Study Name: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
Condition: Adult T-Cell Leukemia-Lymphoma
Date: 2012-11-07
Interventions: Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily
Completed Study Name: A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Condition:
  • Adult T Cell Leukemia
  • Adult T Cell Lympho
    Date: 2011-05-12
    Interventions:
    • Drug: IMTOX-25 This agent is s
Recruiting Study Name: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Condition:
  • Adult T-cell Leukemia-Lymphoma
  • ATLL

Date: 2016-04-10
Interventions:
  • Drug: Belinostat Belinostat wi
Completed Study Name: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
Condition:
  • Adult T-cell Leukemia
  • Lymphoma

Date: 2005-09-01
Interventions:
  • Drug: VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis
Next >>>